Blood Glucose Awareness Training Delivered Over the Internet by Cox, Daniel et al.
Blood Glucose Awareness Training






OBJECTIVE — Blood glucose awareness training (BGAT), a psycho-educational interven-
tion, trains individuals with type 1 diabetes to 1) detect/interpret internal cues to better detect
extreme blood glucose levels, e.g., neurogenic and neuroglycopenic symptoms; and 2) interpret
external cues to detect current and anticipate future extreme blood glucose levels, e.g., insulin
timing/doseandrecentself-monitoringofbloodglucoseresults.Althoughoutcomestudiesusing
BGAT are signiﬁcant, limitations include the requirement of eight weekly meetings and limited
professionals trained to deliver BGAT.
RESEARCH DESIGN AND METHODS — Due to the limitations mentioned above,
BGAT was converted for web-based delivery. The internet allows BGAT delivery to be dynamic,
engaging, convenient, and personalized. Efﬁcacy was evaluated usinga2( B G AThome, n  20,
vs. control, n  20)  2 (pre/post) design.
RESULTS —B G AThome was judged as useful and easy to use, was completed by 94% of the
participants, and resulted in signiﬁcant clinical improvements (P  0.05).
CONCLUSIONS — The internet may be an efﬁcient and effective means of delivering dia-
betes interventions like BGAT.
Diabetes Care 31:1527–1528, 2008
T
hirteen U.S. and European studies
have documented the beneﬁts of
blood glucose awareness training
(BGAT) (1). These beneﬁts include im-
provementsindetectingandreducingthe
occurrencesofextremebloodglucoselev-
els and their sequelae, e.g., reducing
occurrence of ketoacidosis, severe hypo-
glycemia, hypoglycemia-related driving
mishaps, and fear of hypoglycemia. We
hypothesized that an internet version of
BGAT would be perceived as useful, be
completed efﬁciently, and produce
greater clinical beneﬁts compared with a
wait-list control group.
RESEARCH DESIGN AND
METHODS— A notice in Diabetes
Forecast inviting participants to evalu-
ate BGAThome.com resulted in 210
individuals completing an online
screening in 10 days. Participants were
the ﬁrst 40 individuals who, by tele-
phone interviews, met the following
inclusion criteria: type 1 diabetes, rou-
tinely measuring blood glucose levels
more than twice a day, and willingness
todevote1–2h/weekfor8–10weeksto
completing BGAThome. Of 108 re-
sponders telephoned, 38 were unreach-
able, 14 were ineligible, and 10 declined
participation (Table 1).
After signing institutional review
board–approved informed consent, par-
ticipants were mailed a handheld com-
puter (HHC) and a LifeScan One-Touch
meter with supplies for one month’s use.
Participants were instructed to 1) activate
the HHC before performing routine self
monitoring of blood glucose (SMBG); 2)
enter an estimate of their current blood
glucose level; 3) based on this estimate,
indicate whether they should then eat
fast-acting carbohydrates, engage in vig-
orous exercise, or drive; and 4) perform
SMBG and record their actual blood glu-
cose levels. After returning the HHC,
participants completed online a demo-
graphic questionnaire, the Diabetes
Knowledge Scale, and the Hypoglycemia
Fear Survey (2). The HHC and question-
naire data were collected again 12 weeks
later,alongwithLikert-scaleitemsassess-
ing BGAThome’s beneﬁts and usability.
Users were given 12 weeks to com-
plete BGAThome’s units, detailed else-
where (1). Central to BGAT is com-
pleting daily blood glucose diaries, in
which participants 1) record relevant
blood glucose information and symp-
toms, 2) estimate their current blood
glucose, 3) receive feedback on their es-
timate accuracy by performing and re-
cording SMBG, 4) interpret the clinical
signiﬁcance of their accuracy with the
error grid (2), and 5) anticipate their
bloodglucoselevel1hlater.Toencour-
age use of blood glucose diaries, partic-
ipantswereonlygivenaccesstothenext
unit 7 days following completion of the
previous unit.
With internet delivery to a hetero-
geneous sample, individuals would be
expected to pursue BGAT for various
reasons. Thus, the primary outcome
variablewouldneedtoincorporateava-
rietyofpossibledesiredoutcomes.Con-
sequently, our Improved Functioning
Score (IFS) is a composite score where
assessment-dependent variables are
converted to Z scores. Assessment 2
performance was converted to Z scores
basedonassessment1’smeanandSD.Z
scores for each outcome variable were
totaled, where zero reﬂects average
baseline functioning for all variables
and 1 reﬂects performance across all
variables one SD above the sample’s
baseline mean (3). It incorporated the
following variables from question-
naires: Diabetes Knowledge Scale (per-
cent correct) and Hypoglycemic Fear
Survey (sum of Worry subscale). It also
incorporated the following variables
from the HHC: percent SMBG readings
within target range (3.9 10 .0 mmol/
l), number of undetected blood glucose
readings 3.9 mmol/l, overall blood
glucose estimation accuracy (Accuracy
Index) (4), when blood glucose levels
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sions to drive, not eat fast-acting carbo-
hydrates, and exercise.
RESULTS— Two wait-list control
group participants and one BGAThome
participant dropped out during the treat-
ment period. Two BGAThome partici-
pants dropped out during assessment 1.
ANOVA demonstrated that BGAT-
home resulted in greater improvement in
IFS: interaction F(1,33)  4.20; P  0.048
(Table 1). On a scale of 1–5 in which 1 
Not at all and 5  Very, treatment partici-
pants rated BGAThome as beneﬁcial, easy
to use, and enjoyable (3.8  1.17, 3.9 
0.73, and 3.8  1.04, respectively).
On average, participants completed
BGAThome in 11 weeks, logged onto
BGAThome.com30.416.51times,and
spent 26.4  16.3 min on each unit.
These measures of use indicate trends to-
ward a relationship between more web-
site use and increased beneﬁts. More time
spentonunitswasassociatedwithgreater
IFSimprovement(r0.36,P0.10).
More frequent log-ons were associated
with greater improvement in knowledge
(r  0.49, P  0.03) and lower blood
glucose levels 50 mg/dl (r  0.54,
P  0.02). Age was not correlated with
IFS improvement; however, education
tended to be associated with improved
IFS (r  0.45, P  0.07).
CONCLUSIONS —B G AThome was
found to be beneﬁcial, easy to use , and en-
joyable. This is the ﬁrst time BGAT was
made available to individuals with various
goals, needs, diabetes regimens, and re-
sources. Despite this heterogeneity,
BGAThome improved performance,
summed across all eight dependent vari-
ables an average of 2.37 SDs.
Greater BGAThome use appeared to
yieldimprovedbeneﬁts.Engagementmight
be further enhanced by 1) incorporating a
chat room where users share experiences
andsupport;2)employingagroupcontext,
led by a diabetes educator (5); 3) undergo-
ing an initial motivational interview (6); 4)
ﬁscallyinvestingintraining;and5)havinga
pressing personal goal, such as achieving
tight metabolic control because of preg-
nancy without increasing risk of severe hy-
poglycemia (7) or following a costly
hypoglycemia-related driving mishap.
While our ﬁnal participant sample
came from 35 different U.S . cities and 21
different states, allowing greater external
validity, the sample size and its demo-
graphic composition (white, middle-
aged, educated individuals) was a
limitation of this study. A larger, more
representative sample would also allow
investigation into the role of socioeco-
nomic status, race, and education.
Nevertheless, this study indicates the
possible beneﬁts of disseminating BGAT-
home over the internet in a personalized
and self-directed format, serving a large
number of individuals in a cost-effective
manner.
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Table 1—Demographics of participants in the waiting-list control and BGAThome groups
Waiting-list control group BGAThome.com group Comparison values
Demographics
Sample size (n) 18 17
Age (years) 52.7  13.96 43.7  14.06 F(1,33)  3.79, P  0.07
Sex (% female) 56 59 
2  0.04, P  0.85
Race (% white) 100 100
Years of education 15.3  1.71 16.1  1.93 F(1,33)  1.86, P  0.19
Married 78 71 
2  1.13, P  0.57
Age at diagnosis (years) 26.3  16.24 18.9  8.86 F(1,33)  2.79, P  0.11
Height (in) 66.6  13.73 67.6  4.15 F(1,33)  0.54, P  0.47
Weight (lbs) 163.2  30.99 178.3  47.32 F(1,33)  1.26, P  0.28
Dependent variables pre- to posttreatment
Decisions to east fast-acting carbohydrates
when blood glucose is 3.9 mmol/l (%)
35 (25.4) to 25 (30.7) 36 (25.0) to 45 (30.9) F(1,24)  3.73, P  0.07
Decisions not to drive when blood
glucose is 3.9 mmol/l (%)
57 (28.2) to 52 (36.5) 45 (32.6) to 59 (34.1) F(1,24)  2.46, P  0.13
IFS 0.46 (3.8) to 0.60 (4.0) 0.49 (4.0) to 1.87 (4.1) F(1,33)  4.20, P  0.05
Data are means  SD or percent.
BGAThome.com
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